1. Industry-related definitions
A biological laboratory is a place where experiments related to biology are conducted. With the increasingly stringent requirements for quality control, the demand for constant temperature and humidity environment is increasing, and the application field is becoming wider and wider. Generally, there will be biological laboratories in schools, and the blood testing laboratory in hospitals is also a biosafety laboratory. Usually, when you enter the biology laboratory, you are graded according to the different research objects, and there are four levels.
Second, the development status of the industry market
, market size
Since the outbreak of the new crown pneumonia epidemic, many countries have increased investment in biotechnology R&D and industrial development, and the development of the bioeconomy has shown an accelerated trend: the progress of biotechnology has accelerated significantly. At present, many biological laboratories have completed the upgrade of laboratory automation and continue to move forward in the direction of intelligent biological laboratories. Biological laboratory automation mainly focuses on solving the repetitive mechanical work in daily work and reducing the human error of the entire inspection system. The "intelligence" of biological laboratories focuses more on the innovation and implementation of software, data, algorithms and other technologies, and helps biological laboratories to significantly improve from various dimensions such as business, daily management, and academia through new technologies, so as to realize the sustainable development of biological laboratories.
With the development of biotechnology and the post-epidemic era, the market demand for drug research and development, biological experiments and testing has soared. In 2022, the market size of the domestic biological laboratory industry will be 22662.4 billion yuan, an increase of 1939%, as follows:
Source**: Guanyan Report Network.
The market demand for domestic biological laboratories is showing a growing trend, and the market prospects are broad in the future. At the same time, with the continuous development of technology and the continuous expansion of application fields, biological laboratories need to continuously improve the technical level and equipment quality to meet market demand. It is estimated that the market size of China's biological laboratory industry will reach 8216 in 20308.5 billion yuan.
, ** situation
The national laboratory mainly focuses on the major strategic needs of economic and social development and the emerging cross-cutting frontier fields, and builds an experimental platform for interdisciplinary, comprehensive integration and mechanism innovation. China's national laboratories were founded in 1984, as an important strategic innovation force representing the national level, and have been in the exploration and pilot stage since their establishment.
In recent years, the construction of national laboratories has accelerated. At the 2017 National Science and Technology Work Conference, the Ministry of Science and Technology proposed to build a national strategic scientific and technological force under the guidance of national laboratories, and start the construction of national laboratories in major innovation fields in accordance with the principle of "mature one, start one".
List of State Key Biological Laboratories (incomplete statistics).
Source**: Guanyan Report Network.
China attaches great importance to scientific and technological innovation, and has introduced a series of policies to encourage R&D and innovation, and China's research and experimental development funding has continued to grow from 2018 to 2022. In 2022, the domestic investment in research and experimental development will exceed 3 trillion yuan, and the investment intensity will reach 254%。
Source**: Guanyan Report Network.
In 2022, China's basic research funding will exceed 190 billion yuan, reaching 195.1 billion yuan, an increase of 7 over the previous year37%, which greatly promoted the improvement of China's original innovation ability. In 2022, China's basic research funding accounted for 632%, which has remained above 6% for 4 consecutive years.
Source**: Guanyan Report Network.
, demand
Under the influence of the new crown epidemic, **He enterprises have increased their investment in research and development of vaccines, drugs and testing equipment and other related products. At the same time, with the aging population, the increasing health awareness of residents, and the increase in medical and health expenditure, there is also a greater demand for innovative products and services in the life sciences field. China's biotechnology industry has achieved rapid development in recent years, and the market size of China's biotechnology industry will reach 161 trillion yuan, with a CAGR of 13 between 2014 and 202287%。
Source**: Guanyan Report Network.
The biotechnology industry is a wide range of industries covering multiple subdivisions such as biomedicine, gene sequencing, biological reagents and technical services. The biotechnology industry is a national strategic emerging industry, and the state has continuously introduced relevant policies to support the development of the biotechnology industry. During the "14th Five-Year Plan" period, the state proposed to develop and expand strategic emerging industries such as biotechnology, accelerate the innovation and application of key core technologies, promote the integration and innovation of biotechnology and information technology, accelerate the development of biomedicine, biological breeding, biomaterials, bioenergy and other industries, and expand and strengthen the bioeconomy. Driven by national policies, China's biotechnology industry is expected to develop rapidly, and the domestic substitution rate is expected to continue to increase. With the rapid development and widespread application of biotechnology, the demand for biological laboratories will also increase.
3. Industry segment analysis
, inspection and testing biological laboratory
With the development of science and technology, the bioengineering and pharmaceutical industries are developing rapidly, and the demand for biosafety testing is also increasing. Due to the strict supervision of drugs pre-put on the market by the Food and Drug Administration, there is a greater need for prior inspection and certification by professional institutions engaged in biosafety testing services. In order to improve the quality of their products, pharmaceutical companies often need to conduct quality inspections. As the competition in the pharmaceutical market becomes more and more fierce, more and more enterprises realize that only by ensuring product quality can they achieve competitive advantages and higher economic benefits in the market. Patients' requirements for medical services and medical devices and their attention to drug quality are also increasing, which promotes pharmaceutical companies to pay more attention to drug quality and safety, and strengthen pharmaceutical quality testing. In 2022, the market size of China's inspection and testing biological laboratory industry will be 7931.8 billion yuan, as follows:
Source**: Guanyan Report Network.
, research and development biological laboratory
R&D biological laboratories are laboratories set up for some problems that need to be solved through research and development, which may be some chemical synthesis, reaction mechanism, production process, optimization scheme, formula screening, detection methods, effect verification, etc.
Since 2020, China's policies for the innovative drug industry at the national level have continued to focus"Encourage the research and development of innovative drugs and accelerate the listing of new drugs"。The main objective of the policy is to promote the development of domestic innovative drugs to meet the growing medical demand, and to accelerate the approval and marketing process of innovative drugs to bring innovations** to market more quickly for the benefit of patients. As of 2022, the market size of China's R&D biological laboratory industry is 14730.6 billion yuan, as follows:
Source**: Guanyan Report Network.
Fourth, the analysis of the industry competition pattern
Market entities in the biological laboratory industry can be divided into public scientific research institutions and private institutions.
In terms of public scientific research institutions, up to now, China has formed a high-level biosafety laboratory system with a relatively reasonable regional layout, a relatively complete functional positioning, a relatively full role, and a relatively standardized operation and management. Specifically, at present, there are 81 biosafety** (P3) laboratories in China that have passed the construction review of the Ministry of Science and Technology, and 2 biosafety level 4 (P4) laboratories are officially in operation. These high-level biosafety laboratories have played an important platform role in the prevention and control of infectious diseases, emergency response to public health emergencies, prevention and control of animal and plant diseases, medical research, inspection and quarantine, and national defense biosecurity, and have become an important support for national capabilities.
In terms of private institutions, with the improvement of people's demand for medical and health care and the continuous development of testing technology, the demand for testing services is rising, and the number of research projects is increasing, and hospitals, as the only subject of medical testing business, can no longer meet the actual situation of the development of testing and diagnosis business. The biological laboratory outsources the inspection business that originally belonged to the laboratory department and pathology department of the hospital for centralized inspection, which has a significant scale effect, and improves the inspection efficiency and inspection level through large-scale operation and professional division of labor.
At present, China's ICL (third-party medical testing laboratory) market is developing rapidly, and the domestic competition pattern is basically formed. The mainstream model of the domestic ICL industry is to feed back the results to the hospital after receiving samples and testing, so intensive operation and professional division of labor are the core competition of independent medical laboratories. Relying on the first-mover advantage, Jinyu Medical, Dian Diagnostics and Adicon have carried out network layout in major cities across the country, taking the lead in forming intensive management advantages, and have become the top three enterprises in the industry in terms of market share for many years. Jinyu Medical and Dian Diagnostics have a market share of more than 50%, and as industry leaders, they have obvious competitive advantages, and the ICL industry has also formed an oligopoly pattern.
The main brand of China's biological laboratory industry
Source**: WWTQ
Note: The above information is for reference only, please refer to the body of the report for details.
The "Research Report on the Development of China's Biolaboratory Industry In-depth Analysis and Investment Prospects (2024-2031)" released by Guanyan Report Network covers the latest industry data, market hotspots, policy planning, competitive intelligence, market prospects, investment strategies, etc. It is supplemented by a large number of intuitive charts to help enterprises in the industry accurately grasp the development trend of the industry, market trends, and correctly formulate corporate competitive strategies and investment strategies. Based on authoritative data released by the National Bureau of Statistics, the General Administration of Customs and the State Information Center, this report combines the environment in which the industry is located, and conducts market research and analysis from multiple perspectives such as theory to practice, from macro to micro.
The industry report is one of the important decision-making bases for enterprises, relevant investment companies and first-class departments in the industry to accurately grasp the development trend of the industry, gain insight into the industry competition pattern, avoid business and investment risks, and formulate correct competition and investment strategy decisions. This report is an indispensable and important tool for a comprehensive understanding of the industry and for investing in the industry. Over the years, Guanyan has provided professional industry analysis reports for tens of thousands of enterprises, consulting institutions, financial institutions, industry associations, individual investors, etc., and its customers include Huawei, PetroChina, China Telecom, China Construction, HP, Disney and other leading enterprises at home and abroad, and have been widely recognized by customers.
Outline of the Table of Contents].Chapter 1 2019-2023Overview of the development of China's biolaboratory industry
Section 1 Overview of the development of the biological laboratory industry.
1. Relevant definitions of the biological laboratory industry.
2. Analysis of the characteristics of biological laboratories.
3. Introduction to the basic situation of the biological laboratory industry.
Fourth, the business model of the biological laboratory industry.
1. Production mode.
2. Procurement mode.
3. Sales and service model.
5. Analysis of the main demand of the biological laboratory industry.
Section 2 Life Cycle Analysis of China's Biolaboratory Industry.
1. Overview of the life cycle theory of the biological laboratory industry.
2. Life cycle analysis of the biological laboratory industry.
Section 3 Analysis of Economic Indicators of the Biological Laboratory Industry.
1. Profitability analysis of the biological laboratory industry.
2. Analysis of the economic cycle of the biological laboratory industry.
3. Analysis of the improvement space of added value in the biological laboratory industry.
Chapter 2 2019-2023Analysis of the market development status of the global biological laboratory industry
Section 1 Review of the development process of the global biological laboratory industry.
Section 2 Market size and regional distribution of the global biolaboratory industry.
Section 3 Regional Market Analysis of Asian Biolaboratory Industry.
1. Analysis of the market status of the Asian biological laboratory industry.
2. Analysis of the market size and market demand of the Asian biolaboratory industry.
3. Analysis of the market prospect of the Asian biological laboratory industry.
Section 4 Regional Market Analysis of North American Biolaboratory Industry.
1. Analysis of the market status of the North American biological laboratory industry.
2. Analysis of the market size and market demand of the North American biolaboratory industry.
3. Analysis of the market prospect of the North American biological laboratory industry.
Section 5 Regional Market Analysis of European Biolaboratory Industry.
1. Analysis of the market status of the European biological laboratory industry.
2. Analysis of the market size and market demand of the European biological laboratory industry.
3. Analysis of the market prospect of the European biological laboratory industry.
Section 6 Distribution trend of the world's biological laboratory industry from 2024 to 2031**.
Section 7 Global Biolaboratory Industry Market Size 2024-2031**.
Chapter IIIAnalysis of the industrial development environment of China's biological laboratory industry
Section 1 Analysis of China's Macroeconomic Environment.
Section 2 Analysis of the impact of China's macroeconomic environment on the biological laboratory industry.
Section 3 Analysis of the Policy Environment of China's Biolaboratory Industry.
1. The current situation of the industry regulatory system.
Second, the main policies and regulations of the industry.
3. Main industry standards.
Section 4 Analysis of the impact of the policy environment on the biological laboratory industry.
Section 5 Analysis of the Industrial Social Environment of China's Biolaboratory Industry.
Chapter IVThe situation of China's biological laboratory industry
Section 1 Introduction to the development of China's biological laboratory industry.
1. Review of the development process of the industry.
2. Analysis of industry innovation.
3. Analysis of the development characteristics of the industry.
Section 2 Market Size Analysis of China's Biolaboratory Industry.
1. Factors affecting the market size of China's biological laboratory industry.
Second, the market size of China's biological laboratory industry.
3. Analysis of the market size of China's biological laboratory industry.
Section 3 Analysis of China's Biological Laboratory Industry.
1. The largest scale of China's biological laboratory industry.
Second, the characteristics of China's biological laboratory industry.
Section 4 Analysis of the demand of China's biological laboratory industry.
1. The scale of demand in China's biological laboratory industry.
2. Characteristics of the demand of China's biological laboratory industry.
Section 5 Analysis of the balance between supply and demand in China's biological laboratory industry.
Chapter 5Analysis of the industrial chain and market segments of China's biological laboratory industry
Section 1 Overview of the Industrial Chain of China's Biological Laboratory Industry.
1. Introduction to the principle of the industrial chain model.
Second, the operation mechanism of the industrial chain.
3. Biological laboratory industry chain**.
Section 2 Analysis of the industrial chain of China's biological laboratory industry.
First, the development status of upstream industries.
2. Analysis of the impact of the upstream industry on the biological laboratory industry.
Third, the development status of downstream industries.
4. Analysis of the impact of downstream industries on the biological laboratory industry.
Section 3 Analysis of the market segments of China's biological laboratory industry.
First, market segment one.
Second, market segment two.
Chapter 6 2019-2023Market competition analysis of China's biological laboratory industry
Section 1 Analysis of the current situation of competition in China's biological laboratory industry.
1. Analysis of the competitive landscape of China's biological laboratory industry.
Second, the main products of China's biological laboratory industry
Section 2 Analysis of the Concentration of China's Biological Laboratory Industry.
1. Analysis of the influencing factors of market concentration in China's biological laboratory industry.
2. Analysis of the market concentration of China's biological laboratory industry.
Section 3 Analysis of the Competition Characteristics of China's Biological Laboratory Industry.
1. Characteristics of regional distribution of enterprises.
Second, the distribution characteristics of enterprise scale.
3. Characteristics of the distribution of enterprise ownership.
Chapter 7 2019-2023Model analysis of China's biological laboratory industry
Section 1 Analysis of the Competition Structure of China's Biological Laboratory Industry (Porter's Five Forces Model).
1. The principle of Porter's Five Forces Model.
Second, the bargaining power.
3. Bargaining power of buyers.
Fourth, the threat of new entrants.
5. Threat of substitutes.
Sixth, the degree of competition in the same industry.
7. Conclusion of Porter's Five Forces Model.
Section 2 SWOT analysis of China's biological laboratory industry.
1. Overview of the SOWT model.
Second, the analysis of industry advantages.
Third, the disadvantages of the industry.
Fourth, industry opportunities.
5. Industry threats.
6. Conclusions of SWOT analysis of China's biological laboratory industry.
Section 3 Analysis of the Competitive Environment of China's Biological Laboratory Industry (PEST).
1. Overview of the PEST model.
Second, policy factors.
3. Economic factors.
Fourth, social factors.
Fifth, technical factors.
6. Conclusions of PEST model analysis.
Chapter 8 2019-2023Analysis of the demand characteristics and dynamics of China's biological laboratory industry
Section 1 Market dynamics of China's biolaboratory industry.
Section 2 Analysis of the characteristics of the consumer market of China's biological laboratory industry.
1. Demand preference.
2. Preferences.
3. Brand preference.
4. Other preferences.
Section 3 Analysis of the cost structure of the biological laboratory industry.
Section 4 Analysis of influencing factors in the biological laboratory industry.
1. Supply and demand factors.
Second, the cost factor.
3. Other factors.
Section 5 Analysis of the current situation of China's biological laboratory industry.
Section 6 Average Trend of China's Biological Laboratory Industry.
1. Analysis of the average trend of China's biological laboratory industry.
2. Factors influencing the average change in China's biological laboratory industry.
CHAPTER IXMonitoring of the operation data of the industry to which China's biological laboratory industry belongs
Section 1 Analysis of the overall scale of China's biological laboratory industry.
1. Analysis of the number and structure of enterprises.
2. Analysis of the scale of industry assets.
Section 2 Analysis of the production, sales and cost of China's biological laboratory industry.
1. Current assets.
Second, sales revenue analysis.
3. Liability analysis.
Fourth, the analysis of profit scale.
5. Analysis of output value.
Section 3 Analysis of the Financial Indicators of China's Biological Laboratory Industry.
1. Industry profitability analysis.
2. Analysis of the solvency of the industry.
3. Analysis of industry operating capabilities.
Fourth, the analysis of industry development capabilities.
Chapter 10 2019-2023Analysis of the regional market status of China's biological laboratory industry
Section 1 Analysis of the regional market size of China's biological laboratory industry.
1. Factors affecting the regional market distribution of the biological laboratory industry.
2. Regional market distribution of China's biological laboratory industry.
Section 2 Market Analysis of Biological Laboratory Industry in East China.
1. Overview of East China.
2. Analysis of the economic environment in East China.
3. Market analysis of the biological laboratory industry in East China.
1) The market size of the biological laboratory industry in East China.
2) The market status of the biological laboratory industry in South China.
3) The market size of the biological laboratory industry in East China**.
Section 3 Market Analysis in Central China.
1. Overview of Central China.
2. Analysis of the economic environment in central China.
3. Market analysis of the biological laboratory industry in Central China.
1) The market size of the biological laboratory industry in Central China.
2) The market status of the biological laboratory industry in central China.
3) The market size of the biological laboratory industry in Central China**.
Section 4 Market Analysis in South China.
1. Overview of South China.
2. Analysis of the economic environment in South China.
3. Market analysis of the biological laboratory industry in South China.
1) The market size of the biological laboratory industry in South China.
2) The market status of the biological laboratory industry in South China.
3) The market size of the biological laboratory industry in South China**.
Section 5 Market Analysis of Biological Laboratory Industry in North China.
1. Overview of North China.
2. Analysis of the economic environment in North China.
3. Market analysis of the biological laboratory industry in North China.
1) The market size of the biological laboratory industry in North China.
2) The market status of the biological laboratory industry in North China.
3) The market size of the biological laboratory industry in North China**.
Section 6 Market Analysis in Northeast China.
1. Overview of the Northeast region.
2. Analysis of the economic environment in Northeast China.
3. Market analysis of the biological laboratory industry in Northeast China.
1) The market size of the biological laboratory industry in Northeast China.
2) The market status of the biological laboratory industry in Northeast China.
3) The market size of the biological laboratory industry in Northeast China.
Section 7 Market Analysis in Southwest China.
1. Overview of the Southwest Region.
2. Analysis of the economic environment in southwest China.
3. Market analysis of the biological laboratory industry in Southwest China.
1) The market size of the biological laboratory industry in Southwest China.
2) The market status of the biological laboratory industry in Southwest China.
3) The market size of the biological laboratory industry in Southwest China**.
Section 8 Market Analysis in Northwest China.
1. Overview of the Northwest Territories.
2. Analysis of the economic environment in Northwest China.
3. Market analysis of the biological laboratory industry in Northwest China.
1) The market size of the biological laboratory industry in Northwest China.
2) The market status of the biological laboratory industry in Northwest China.
3) The market size of the biological laboratory industry in Northwest China**.
Chapter XIAnalysis of companies in the biological laboratory industry (adjusted as data is updated).
Section 1 Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
1. Main economic indicators.
2. Analysis of corporate profitability.
3. Analysis of corporate solvency.
4. Analysis of enterprise operation capabilities.
5. Analysis of enterprise growth ability.
Fourth, the company's advantages analysis.
Section 2: Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages and disadvantages analysis.
Section 3: Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages analysis.
Section 4 Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages analysis.
Section 5 Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages analysis.
Section 6 Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages analysis.
Section 7: Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages analysis.
Section 8 Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages analysis.
Section 9 Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages analysis.
Section 10 Enterprises.
First, the company profile.
Second, the main products.
3. Operation.
Fourth, the company's advantages analysis.
Chapter 12 2024-2031Analysis of the development prospects of China's biological laboratory industry
Section 1 Analysis of the future development prospects of China's biological laboratory industry.
1. Analysis of the domestic investment environment of the biological laboratory industry.
2. Analysis of market opportunities in China's biolaboratory industry.
3. The growth rate of investment in China's biological laboratory industry**.
Section 2 Future Development Trends of China's Biolaboratory Industry**.
Section 3 Scale Development of China's Biological Laboratory Industry**.
1. The market size of China's biological laboratory industry.
2. The growth rate of the market size of China's biological laboratory industry**.
3. The output value of China's biological laboratory industry is **.
Fourth, the growth rate of the output value of China's biological laboratory industry.
5. Supply and demand of China's biological laboratory industry**.
Section 4 Profit Trend of China's Biological Laboratory Industry**.
Chapter 13 2024-2031Analysis of entry barriers and investment risks in China's biolaboratory industry
Section 1 Analysis of Barriers to Entry in China's Biolaboratory Industry.
1. Analysis of financial barriers in the biological laboratory industry.
2. Analysis of technical barriers in the biological laboratory industry.
3. Analysis of talent barriers in the biological laboratory industry.
Fourth, the analysis of brand barriers in the biological laboratory industry.
5. Analysis of other barriers in the biological laboratory industry.
Section 2 Risk Analysis of the Biological Laboratory Industry.
1. Macro environmental risks in the biological laboratory industry.
2. Technical risks in the biological laboratory industry.
3. Competitive risks in the biological laboratory industry.
Fourth, other risks in the biological laboratory industry.
Section 3 Problems in China's Biological Laboratory Industry.
Section 4 Analysis of Problem Solving Strategies in China's Biolaboratory Industry.
Chapter 14 2024-2031Research conclusions and investment suggestions of China's biological laboratory industry
Section 1 A review of the research on China's biological laboratory industry in Guanyan World.
First, the investment value of the industry.
2. Industry risk assessment.
Section 2 Analysis of the entry strategy of China's biological laboratory industry.
First, the target customer group of the industry.
Second, the selection of market segments.
Third, the choice of regional market.
Section 3 Analysis of Marketing Strategies in the Biological Laboratory Industry.
1. Product strategy of the biological laboratory industry.
2. Pricing strategy of the biological laboratory industry.
3. Channel strategy of the biological laboratory industry.
Fourth, the best strategy of the biological laboratory industry.
Section 4 Investment Advice from Analysts.
See the main text of the report for details of the chart